Neutrophils are involved in the pathogenesis of allergy. However, the contribution of the different functionally polarized neutrophils in allergy needs to be clarified. We sought to define the characteristics of interleukin (IL)-33-induced neutrophils and the involvement of this subset of polarized neutrophils in allergic pathogenesis. Freshly isolated neutrophils were treated with different cytokines and the cytokine expression levels were detected by realtime PCR. The gene expression profile of IL-33-induced neutrophils was determined by microarray assay. Adoptive transfer assay was used to investigate the function of IL-33-induced neutrophils in an ovalbumin (OVA)-induced allergic asthma model. IL-33-treated neutrophils selectively produced IL-4, IL-5, IL-9 and IL-13 (referred as to N (IL-33) cells) and displayed a distinctive gene expression profile in sharp contrast to resting and lipopolysaccharide (LPS)-treated neutrophils. IL-33-induced neutrophils expressed high Levels of IL-1R2 on cell surface, whereas resting and LPS-treated neutrophils did not, indicating IL-1R2 might be used as a biomarker for N(IL-33) cells. Importantly, N(IL-33) neutrophils exist in the lungs of OVA-induced allergic asthma mice. Adoptive transfer of N (IL-33) neutrophils significantly promotes the severity of the lung pathogenesis in this model. IL-33 induces neutrophil polarization through c-Jun N-terminal kinase-and nuclear factor-κB-dependent pathways. A previously unappreciated neutrophil polarization driven by IL-33 with unique cell surface markers and cytokine/chemokineproducing gene profile was defined. The newly identified N(IL-33) subpopulation may have significant contribution to IL-33-related pathogenesis.
INTRODUCTION
Neutrophils (also called polymorphonuclear neutrophil granulocytes) are the most abundant white blood cells in circulation and one of the earliest immune cells recruited to the sites of infection and inflammatory response. Neutrophils that are fully equipped with a variety of granules are essential to host defense against intruding microorganisms and have a critical role in initiating inflammation and innate immunity. 1 However, it is highly recognized now that neutrophils also significantly contribute to the various acute and chronic pathological damages in infections, autoimmune diseases and graft rejections in positive or negative ways. [2] [3] [4] [5] In fact, beyond cytotoxicity against invading pathogens, neutrophils can switch phenotypes and exert immune-regulatory functions on both innate and adaptive immunity, including dendritic cells, macrophages, natural killer cells, T cells and B cells. 6,7 1 Neutrophils from rheumatoid arthritis patients upregulate major histocompatibility complex class II expression and increase their antigen-presentation ability, leading to T lymphocyte activation. 8 Recent studies indicate that neutrophils exhibit considerable plasticity and polarization. They have highly variable transcriptome profiles depending on their tissue location and microenvironment. 9 Immunoregulatory agent everolimus can promote the transition of neutrophil from proinflammatory activation to anti-inflammatory model. 10 Akin to macrophage activation pathways, neutrophils have distinct subsets, as presented in infections and tumors. [11] [12] [13] A subpopulation of neutrophils present in the spleen produces BAFF, APRIL, CD40L and interleukin-21 (IL-21), activates marginal-zone B cells and promotes immunoglobulin class switching, somatic hypermutation and antibody production. 14 Tumor-associated neutrophils were proposed to be polarized between antitumorigenic and protumorigenic neutrophil phenotypes. 15 Our recent results also reveal that IL-23-activated neutrophils expresses a unique gene expression profile and participate in the pathological process of colitis. 16 The extracellular inducing factors, the intracellualr molecular regulatory networks, the phenotype characteristics and the biological significance of the polarized neutrophils urgently need to be clarified.
IL-33, a member of the IL-1 family, is not only localized in the cell nucleus but also functions as a cell-free cytokine. 17 Administration of IL-33 into mice caused massive infiltrations of tissues by eosinophils, epithelial goblet cell hyperplasia and elevations of typical type 2 cytokines such as IL-5, IL-9 and IL-13, contributing to allergy and fibrosis. [18] [19] [20] These responses also occurred in T-and B-cell-deficient Rag knockout recipient mice, indicating that innate cells, including innate lymphoid cells (ILCs), were the important target of IL-33. 19, 21 Neutrophils can act as target cells for IL-33 in the lungs. IL-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. 22 There are a large number of neutrophils marginated in lung capillaries. They are key regulatory cells in the immunopathogenesis of asthma. 23, 24 In the present study, we demonstrate that IL-33-treated neutrophils selectively produced IL-4, IL-5, IL-9 and IL-13 (referred as to N(IL-33) cells) and displayed a distinct gene expression profile in sharp contrast to resting and lipopolysaccharide (LPS)-treated neutrophils (N(LPS)). Importantly, N(IL-33) neutrophils existed in the lung tissue of ovalbumin (OVA)-induced asthma mice. Adoptive transfer of N(IL-33) neutrophils significantly promoted the severity of the lung pathogenesis in this model. IL-33 induced N(IL-33) neutrophil polarization through c-Jun N-terminal kinase (JNK)-and nuclear factor (NF)-κB-dependent pathways. Thus our findings reveal a previously unappreciated neutrophil polarization driven by IL-33 with unique cell surface markers and cytokine/chemokine-producing gene profile. The newly identified N(IL-33) subpopulation may have significant contribution to IL-33-related pathogenesis, such as asthma.
MATERIALS AND METHODS
Mice Six-to-eight-week old male C57BL/6 (B6) mice were purchased from Beijing University Experimental Animal Center (Beijing, China). IL-33 transgenic mice (C57BL/6J-TgN(CMV-IL33) ZLFILAS, IL-33-TG) were kindly offered by the Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health; Institute of Laboratory Animal Science, CAMS and PUMC. 25 All the mice were maintained and bred in specific pathogenfree conditions. All experimental manipulations were undertaken in accordance with the Institutional Guidelines for the Care and Use of Laboratory Animals, Institute of Zoology (Beijing, China).
Reagents
The following cytokines were purchased from PeproTech (Rocky Hill, CT, USA): recombinant mouse IL-1β, IL-2, IL-6, IL-10, IL-12, IL-13, IL-17A, interferon (IFN)-γ and tumor necrosis factor (TNF)-α. The following cytokines were purchased from R&D Systems (Minneapolis, MN, USA): IL-4, IL-21, IL-23, IL-33, transforming growth factor (TGF)-β1 and granulocyte macrophages colony-stimulating factor (GM-CSF). LPS was offered by Sigma-Aldrich (St Louis, MO, USA). G-CSF was bought from Biovision (Milpitas, CA, USA). The concentrations of the recombinant mouse cytokines were used based on our previous studies. 26 Except for experiments with treatment of different concentrations of IL-33, IL-33 was used at 100 ng/ml in other experiments.
Phycoerythrin (PE)-cy5-conjugated anti-CD11b (M1/70) and PE-conjugated anti-F4/80 (BM8) were purchased from eBioscience (San Diego, CA, USA). Fluorescein isothiocyanateconjugated anti-Ly6G (1A8), PE-conjugated anti-IL-1R2 (4E2), PE-conjugated anti-mSiglec F (E50-2440) were purchased from BD Biosciences Pharmingen (San Diego, CA, USA). PE-conjugated anti-mIL-9 (RM9A4) was purchased from Biolegend (San Diego, CA, USA). IL-4 (431104), IL-9 (434804) and IL-5 (431204) Enzyme-linked immunosorbent assay (ELISA) kits were purchased from Biolegend. TNF-α (430904), IL-1β (BMS6002), IL-13 (88-7137), C-C motif chemokine ligand 2 (CCL2; 88-7391) and CCL7 (BMS6006INST) ELISA kits were from eBioscience.
Selective signal transducer and activator of transcription factor 3 (STAT3) inhibitor (NSC74859; 4655/10) was purchased from R&D Systems. P38 inhibitor (SB203580; 559389-1MG) was from The Merck Group (Darmstadt, Germany). STAT1 inhibitor (MTA) and extracellular signal-regulated kinase (ERK) inhibitor (PD98059, 9900) were from Cell Signaling Technology (Danvers, MA, USA). JNK inhibitor (SP600125, S5567) was purchased from Sigma-Aldrich. NF-κB activator inhibitor (481406) was from Calbicohem (Temecula, CA, USA). The OVA and Alum were purchased from Sigma-Aldrich. The primary antibodies against p-JNK (Thr183/ Tyr185), JNK, p-p38 (Thr180/Tyr182), p38, p-STAT1 (Ser727), STAT1, p-ERK (Thr202/Tyr204), ERK, p-p65 (Ser536), p65 and H3 were purchased from Cell Signaling Technology. Anti-β-Actin monoclonal antbody (mAb) was purchased from Sigma-Aldrich. The concentrations of these reagents are used as detected in our previous studies. 27, 28 Isolation and differentiation of neutrophils in vitro Primary neutrophils (CD11b + Ly6G + F4/80 − , referred as to N0 cells) were isolated from bone marrow cells with 52% percoll (GE Healthcare Life Sciences, Piscataway, NJ, USA, 17-0891-01) and sorted by MoFlo XDP (Beckman Coulter, Brea, CA, USA). 29 Unless specifically noted in the figure legend, primary neutrophils (2 × 10 6 cells/ml in 48-well plates) were differentiated under N(LPS) condition (LPS, 1 μg/ml) for 6 h or N (IL-33) condition (IL-33, 100 ng/ml) for 24 h in Dulbecco's modified Eagle's medium with 10% (v/v) fetal bovine serum at 37°C and 5% CO 2 .
Microarray analysis
Microarray procedure was performed according to the manufacturer's instructions and previous reports. 16 R (version 3.0.2) was used to draw the heatmap of lineage-restricted genes. The fold changes were calculated as the ratio of the expression level in each cell type versus the second highest expression level in all cell types. Differentially expressed genes were defined as genes with at least twofold variance of expression levels in N(LPS) and N(IL-33) neutrophils compared with N0 neutrophils.
Quantitative PCR analysis
Total RNA was isolated with TRIzol (Invitrogen, Carlsbad, CA, USA) and reverse transcription was performed with M-MLV superscript reverse transcriptase as described previously. Realtime PCR was performed using multiple kits (SYBR Premix Ex TaqTM, DRR041A, Takara Bio, Kusatsu, Japan) on CFX96 (Bio-Rad, Hercules, CA, USA). The used primers are summarized in Table 1 . The mRNA expression of each gene was normalized to the housekeeping gene hypoxanthinephosphoribosyl transferase (HPRT) as reported previously. 27 The data are shown as the ratios of the interested genes to HPRT. For the inhibitor assay, cells were pretreated with various inhibitors for 30 min respectively, and then treated with IL-33 for 24 h.
Flow cytometry
For flow cytometric analysis of surface markers, cells were stained with antibodies in phosphate-buffered saline (PBS) containing 0.1% (w/v) bovine serum albumin (BSA) and 0.1% NaN 3 . For detection of intracellular cytokines, neutrophils were treated with GolgiPlug (BD Biosciences, San Jose, CA, USA) for the last 4-6 h of incubation. Cells were fixed and permeabilized according to the manufacturer's protocol (BD Biosciences) and stained with anti-IL-9 mAb (1:100). Flow cytometric data were acquired on a FACSCalibur (BD Biosciences) or Epics XL (Beckman Coulter) and analyzed with the CellQuest Version 5.1 software or FlowJo Version 7.6.5 software (TreeStar, San Carlos, CA, USA).
Western blotting
Neutrophils were cultured in 1640 medium with 10% fetal calf serum in six-well plates. Cells were treated with IL-33 (100 ng/ml) for the indicated times. Total or nuclear cell lysates and immunoblot analysis were performed as described previously. 30 Protein concentration was determined by bicinchoninic acid assays. Protein bands were visualized by adding horseradish peroxidase substrate (Millipore, Temecula, CA, USA) and then scanned using the Tanon 1600R Gel Image System (Tanon Co., Ltd., Shanghai, China). Anti-Actin and anti-H3 mAbs were used as cytoplasm and nuclear protein loading control, respectively.
ELISA assays
Cells were treated with LPS (1 μg/ml) and IL-33 (100 ng/ml) for the indicated times. Concentrations of cytokines and chemokines in cell culture medium supernatant were measured by ELISA assay kits, according to the manufacturer's instructions.
Immunofluorescent staining
Cells cultured on coverslips were fixed in 4% paraformaldehyde and permeabilized in 0.2% Triton X-100/PBS for 10 min at 4°C, respectively. 26 Cells were blocked for 1 h in 5% BSA/ PBS and incubated with anti-IL-9 (1:100 dilution in blocking buffer) overnight at 4°C. After the wash step in PBS, cells were stained with Hoechst 33342 (4 μg/ml) for 10 min. Photo micrographs were taken using an LSM510META Laser Scanning Microscope (Zeiss, Jena, Germany).
OVA-induced allergic airway inflammation
The wild-type (WT) and IL-33-TG mice were sensitized by intraperitoneal injections of 10 μg OVA and 1 mg alum at days 0 and 14, whereas control mice were sham sensitized only with PBS. From day 21, the mice were exposed to aerosolized OVA (1% w/v) 30 min per day for 3 consecutive days. Mice were assessed 24 h after the last OVA challenge. Neutrophils from WT mice were stimulated with IL-33 and transferred into OVA-presensitized WT recipients at days 19 and 20. The fresh lungs were isolated and weighed before and after roast at 65°C for 1 day to determine the ratio of wet/dry lung. Cell numbers in bronchoalveolar lavage (BAL) fluid were counted by a hemocytometer. Cells in BAL fluid were analyzed by flow cytometry with anti-mCD11b, anti-mSiglec F, anti-mLy6G and anti-mF4/80 mAbs. Cells in BAL fluid from control and asthma mice were stained with anti-IL-9 and anti-IL-1r2 mAbs, respectively. RNA was isolated from lung tissue for real-time PCR analysis. Lungs were fixed with formaldehyde, embedded in paraffin and sectioned and then stained with hematoxylin and eosin (H&E) for evaluation of the infiltration of inflammatory cells.
Statistical analysis
All data were presented as the mean ± s.d. The two-way analysis of variance was used for comparison among multiple groups with the SPSS 16.0 software (SPSS, Chicago, IL, USA). A Mann-Whitney U-test was used to compare between the two groups. A P-value o0.05 was considered to be statistically significant.
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RESULTS
IL-33 selectively induces T helper type 2 (Th2) cytokine expression in neutrophils
Besides their involvement in primary defense against infections, neutrophils produce and release a large variety of cytokines and chemokines either constitutively or upon microenvironmental stimulations, which have a critical role in infections and pathogenesis. 31, 32 To explore the roles of different cytokines on the expression of Th2-type cytokines such as IL-4, IL-5, IL-9 and IL-13 in neutrophils, we first detected the mRNA expression levels of these genes in freshly isolated neutrophils of mouse bone marrow after different cytokines and LPS stimulation for 24 h by real-time PCR. Among the 15 cytokines and LPS tested in this study, only IL-33 significantly promotes IL-4, IL-5, IL-9 and IL-13 expression levels with the exception of GM-CSF, which also induces IL-4 expression, while the untreated resting neutrophils express almost undetectable levels of these Th2 cytokines (Po0.001, Figure 1a ). IL-33 induces the mRNA and protein expression levels of IL-4, IL-5, IL-9 and IL-13 in dose-and time-dependent manners as determined by real-time PCR and ELISA assays (Figures 1b-d) . The expression levels of IL-9 in IL-33-treated neutrophils are further confirmed by flow cytometric and confocal microscopic staining (Figures 1e and f) . To exclude the potential contamination of other immune cells such as T cells, B cells and ILCs during the differentiation process, we sort the neutrophils of naive mice to obtain highly purified CD11b + Ly6G + cells with 499% purity and repeat the same induction experiments. Indeed, the sorted CD11b + Ly6G + cells express high levels of IL-4, IL-5, IL-9 and IL-13 after IL-33 treatment for 24 h (Supplementary Figure 1) . IL-33 simulation can also upregulate all these cytokine expression levels in human neutrophils (Supplementary Figure 2) . Thus IL-33 has the ability to promote Th2-type cytokines IL-4, IL-5, IL-9 and IL-13 expression levels in resting mouse neutrophils in a very specific manner. Forward primer GCAAGACAGAGAACCTAGATCG Reverse primer GATGAGAAAGACCAGGATGAGG Abbreviations: CCL, C-C motif chemokine ligand; CXCL, C-X-C motif chemokine ligand; CCR, C-C motif chemokine receptor; CXCR, C-X-C motif chemokine receptor; HPRT, hypoxanthinephosphoribosyl transferase; IL, interleukin; IL-1R, interleukin-1 receptor.
IL-33 induces a distinct neutrophil gene expression profile
IL-33-induced neutrophil polarization B Sun et al levels of TNF-α and IL-1β, as detected by quantitative PCR and ELISA assays (Figures 2d and e) . In contrast, IL-33-treated neutrophils specifically express IL-4, IL-5, IL-9 and IL-13 at both mRNA and protein levels (Po0.01, Figures 2d and e) . Importantly, LPS and IL-33 induce different chemokine expression patterns (Figure 2f ). LPS induces high levels of chemokine (C-X-C motif) ligand-1 (CXCL1) and chemokine (C-C motif) ligand-5 (CCL5) expression levels in neutrophils but IL-33 does not. Both LPS and IL-33 promote CXCL3, CCL7 and CCL12 expression levels at different expression kinetics (Figure 2f ). LPS rapidly upregulates CXCL3, CCL7 and CCL12 expression levels in neutrophils and then turn downs these genes quickly too (Figure 2f ). However, IL-33 gradually induces CCL7 and CCL12 expression levels in neutrophils in a slower manner than LPS does (Figure 2f) . Importantly, IL-33 but not LPS promotes neutrophils to express high level of CCL2 (Figure 2f ), an important chemotactic factor for attracting monocytes, memory T lymphocytes and natural killer cells to the site of inflammation through binding to C-C motif chemokine receptor 2 (CCR2) and has been implicated in the pathogeneses of diseases, including psoriasis, rheumatoid arthritis, atherosclerosis, multiple sclerosis and insulin-resistant diabetes. 33, 34 Altogether, these data promote us to speculate that IL-33 may drive the polarization of resting neutrophils into an undefined state, which results in the production of a distinct panel of cytokines 
IL-1R2 is specifically expressed on IL-33-induced neutrophils
As an effort to identify the specific cell surface markers and the chemotaxis characteristics of IL-33-induced N(IL-33) neutrophils, we determined the chemokine receptors and other cell surface molecule expression levels on N(IL-33) neutrophils. Microarray analysis showed that resting neutrophils, LPSinduced neutrophils and IL-33-induced neutrophils displayed distinct chemokine receptors and membrane protein geneexpressing profiles (Figure 3a) . Interestingly, IL-33-induced neutrophils preferentially express high levels of C-X-C motif chemokine receptor 1 (CXCR1), CCR1, IL-1R2 and CXCR2 mRNA compared with LPS-induced neutrophils as indicated by real-time PCR assays, while LPS-induced neutrophils express high levels of CXCR5 (Po0.001, Figure 3b ). We further demonstrate that IL-1R2 protein is expressed preferentially on the cell surface of IL-33-induced neutrophils as detected by flow cytometric assays (Figures 3c and d) . Therefore, cell surface IL-1R2 expression may be a potential marker for IL-33-induced N(IL-33) neutrophil subpopulation.
IL-33 induces Th2 cytokine expression in neutrophils via
JNK and NF-κB pathways IL-33 interaction with its receptor ST2 promotes the activations of Erk1/2, p38, JNK and activator protein 1 (AP-1) and translocation of NF-κB to the nucleus. 35 The IL-9 promoter region and two additional regions of conserved non-coding sequences upstream of the promoter region form the cis-and trans-regulatory elements collectively regulating IL-9 gene expression. 36, 37 Sequence and molecular analysis identified the potential binding sites for STATs, nuclear factor of activated T cells, GATA1, GATA3, Smad (Drosophila mothers against decapentaplegic proteins) and notch as well as NF-κB and AP-1. 37, 38 It is true that IL-33 significantly induced the activation of P38-STAT1, JNK, AP-1 and NF-κB in neutrophils, as indicated by their protein phosphorylation and relocalization to the nucleus (Figures 4a and b) . Inhibition of p38 mitogen-activated protein kinase, STAT1, STAT3 and ERK activation by their specific inhibitors, respectively, failed to significantly decrease the IL-9 mRNA expression in IL-33-induced neutrophils (Supplementary Figure 3) . But inhibition of either JNK or NF-κB remarkably impacts IL-33-induced IL-4, IL-5, IL-9, IL-13, CCL2, CCL12 and IL-1R2 expression levels in IL-33-induced neutrophils (Po0.01, Figures 4c and d,  Supplementary Figure 4) . Meanwhile, the concentrations of IL-9, IL-5, IL-13 and CCL2 in the culture medium of IL-33-treated neutrophils were significantly decreased with the increasing doses of JNK inhibitor (SP600125) and NF-κB inhibitor, respectively (Figures 4e and f) . In order to demonstrate that IL-33 acts through ST2 for downstream signaling activation and cytokine production, we used neutrophils isolated from IL-33R(ST2) knockout (KO) mice to perform the similar studies. As expected, ST2 KO neutrophils showed minimal phosphorylation of p65 and JNK after IL-33 treatment (Supplementary Figure 5A) . Meanwhile, IL-33 induced poor expression levels of IL-4, IL-5, IL-9 and IL-13 in ST2-deficient neutrophils (Supplementary Figure 5B) . These results indicated that the expression levels of Th2-type cytokines, CCL2, CCL12 and IL-1R2 in IL-33-induced neutrophils were dependent on JNK-and NF-κB-mediated pathways.
The presence and the roles of N(IL-33) neutrophils in allergic airway inflammatory mice Th2/Th9 cytokines are critically involved in the pathogenesis of airway allergic inflammation in mice and humans. 39, 40 We observed the presence of N(IL-33) neutrophils in an OVAinduced airway allergic inflammatory mouse model, in which Th2/Th9 cells and neutrophils have a critical role as previously reported. IL-9 + and IL-1R2 + neutrophils did exist in the BAL fluid of airway allergic inflammatory mice (Figures 5a and b) . IL-33-TG mice displayed more severe airway allergic inflammatory pathogenesis in the lung tissues as indicated by H&E staining of lung tissues, the ratio of wet/dry lung weight, BAL fluid cell number and the infiltration by leukocytes and eosinophils (Figures 5b-f , and data not shown). In parallel with the pathological changes, lung tissue of IL-33-TG airway allergic inflammatory mice express significantly higher IL-4, IL-5, IL-9, IL-13, CCL2 and CCL7 molecules than those of WT airway allergic inflammatory mice as determined by real-time PCR (Figure 5g ). To identify the role of N(IL-33) cells in the pathogenesis of airway allergic inflammation, we adoptively transferred either induced N(IL-33) or resting N0 neutrophils (5) promoting airway allergic inflammatory pathogenesis. Thus we offered additional evidence for the differentially polarized neutrophils with respect to cytokine and chemokine productions. IL-33 protein is constitutively present in healthy mice and humans, primarily in the nuclei of non-hematopoietic cells, with particular abundance in specialized populations of epithelial and endothelial cells. 41, 42 IL-33 contributes to many diseases, such as allergy, fibrosis, multiple sclerosis, rheumatoid arthritis and so on. 20, 43 Single-nucleotide polymorphism studies showed the association of IL-33-IL-1R-like 1 pathway polymorphisms with asthma in childhood. 44 Blockade of IL-33/ ST2 ameliorates airway inflammation in a mouse model of allergic asthma. 45 Although IL-33 can act on many immune cells to promote the pathogenesis, we found that IL-33, as a cytokine, can directly induce Th2 cytokine productions, including IL-4, IL-5, IL-9 and IL-13, in neutrophils and subsequently promote the process of airway allergic inflammation in a mouse model. IL-9 is secreted by many cell types, including T lymphocytes, eosinophils, mast cells and neutrophils, and is implicated in asthma and in the protection against nematode infections. 46,47 Transgenic expression of IL-9 results in allergic inflammation. 48 In addition, the IL-33-induced Th2 chemokine CCL2 releasing by neutrophils likely recruit more M2 phenotypic macrophages and modulate the switch of Th1 and Th2 cells. 34, 49 The involvement of IL-33-induced N(IL-33) neutrophils in airway allergic inflammation is consistent with the previous reports showing the roles of neutrophils in the pathogenesis of airway allergic inflammation, 50,51 although using CXCR2 antagonist to reduce neutrophil numbers in the lungs did not reduce the frequency of severe exacerbations in patients with uncontrolled severe asthma. 52 This could not exclude the roles of neutrophils in asthma, especially the onset of this disease. Neutrophil extracellular traps can also be generated in asthmatic airways and participate in the disease process. 23, 53 It is reported that neutrophils can produce IL-1β, TNF-α, IL-12, IL-4 and IL-10 under different stimulations. 31 We observed that neutrophils have the ability to release IL-9 and IL-13 after stimulation with IL-33 alone. IL-4 appears to be an important initiator of IL-9 synthesis in CD4 + T cells, as a reduction in IL-9 production has been found after activating CD4 + T cells from IL-4-deficient mice in vitro. 54 Although the requirement for IL-4 in enhancing IL-9 production has been suggested in different models, 55 a significant amount of IL-9 production is present in IL-4-deficient mice upon protein antigen immunization, suggesting an IL-4-independent pathway for IL-9 production. 54 However, in the later case it is unclear whether IL-9 is produced by CD4 + T cells or innate cells such as CD4 + natural killer T cells or CD4 + lymphoid tissue-inducer cells. In the present study, we found IL-33 alone without additional IL-4 supplement can induce IL-9 production in neutrophils, suggesting that IL-4 is not essential for IL-9 expression in resting neutrophils. Molecular studies showed that IL-33 induces Th2 cytokine and chemokine expression levels mainly through JNK and NF-κB-dependent pathways. p38, STAT1, STAT3 and ERK do not significantly participate in IL-33 induction of Th2 cytokine expression levels in neutrophils.
In summary, our present studies demonstrate a Th2/Th9-type-like polarization of neutrophils induced by IL-33. These polarized neutrophils promote the airway allergic inflammatory pathogenesis in a mouse model. Thus we offered additional evidence for the differentially polarized neutrophils with respect to cytokine and chemokine productions. These findings shed light on the presence of neutrophil functional plasticity and polarization, which we previously neglected. The biological significance of the polarized neutrophils in other diseases needs to be investigated, which may provide new insights to the contribution of neutrophils to the pathogenesis caused by inflammatory and immune disorders and may offer novel therapeutic approaches to treat neutrophil-related immune disorders.
